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ABSTRACT 
Fetal hemoglobin (HbF) and peripheral hemoglobin oxygen saturation (SpO 2) both predict clinical 
severity in sickle cell disease (SCD), while reticulocytosis is associated with vasculopathy, but there 
are few data on mechanisms. HbF, SpO2 and routine clinical and laboratory measures were available 
in a Tanzanian cohort of 1175 SCD individuals aged ≥5 years and the association with SpO2 (as 
response variable transformed to a Poisson distribution) was assessed by negative binomial model 
with age and sex as covariates. . Increase in HbF was associated with increased SpO2 (rate ratio, 
RR=1.19; 95% confidence intervals [CI] 1.04, 1.37 per natural log unit of HbF; P=0.0004). In 
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univariable analysis, SpO2 was inversely associated with age, reticulocyte count, and log (total 
bilirubin) and directly with pulse, SBP, hemoglobin, and log (HbF). In multivariable regression 
log(HbF) (RR 1.191; 95%CI 1.04, 1.37; p=0.013), pulse (RR 1.01; 95%CI 1.00, 1.01; p=0.026), SBP (RR 
1.008; 95%CI 1.00, 1.02; p=0.014), and hemoglobin (1.120; 95%CI 1.05, 1.19; p=0.001) were 
positively and independently associated with SpO2 while reticulocyte count (RR 0.985; 95%CI 0.97, 
0.99; p=0.019) was independently inversely associated with SpO2. In SCD, improving SpO2, in part 
through cardiovascular compensation and associated with reduced reticulocytosis, may be a 
mechanism by which HbF reduces disease severity. 
 
KEY WORDS: Fetal hemoglobin (HbF), sickle cell disease, hypoxia, oxygen saturation, reticulocytes 
HIGHLIGHTS  
 Fetal hemoglobin may moderate sickle cell disease through increased oxygen saturation  
 Low oxygen saturation is associated with reticulocytosis which might moderate cerebral 
vasculopathy and stroke risk 
 Higher pulse rate and systolic blood pressure in those with higher SpO2 suggests 
cardiovascular compensation for low SpO2 
 
 
 
 
 
RESEARCH IN CONTEXT  
Fetal hemoglobin (HbF) is normally synthesized during intrauterine life and it starts to decline before 
birth being replaced by adult hemoglobin (HbA). However some individuals continue to synthesize 
HbF to adulthood and are relatively protected from severe sickle cell disease. The mechanism of HbF 
protection in SCD has not been entirely established. This study reports a positive association between 
HbF and oxygen saturation (SpO2). Higher SpO2 is associated with decreased reticulocytes but 
increased pulse rate and systolic blood pressure, suggesting SpO2 is maintained in part through 
cardiovascular compensation. Increasing HbF may reduce disease severity partly through increasing 
SpO2. 
INTRODUCTION 
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Sickle Cell disease (SCD) remains the most common hemoglobinopathy worldwide. Clinically, there is 
great variability amongst individuals with SCD; predictors of severity include hemoglobin F levels, 
reticulocytosis and alpha globin gene number. A major factor is the wide variation in the innate 
ability to synthesize fetal hemoglobin (HbF) beyond early childhood. Individuals with high levels of 
HbF experience milder forms of the disease with lower morbidity and improved survival.  HbF level of 
10% and above is believed to reduce the risk of major organ failure such as stroke, while much 
higher levels (20% and above) may be required to prevent recurrent clinical events such as painful 
crises and pulmonary disorder(Meier et al., 2017). The mechanisms underlying the reduction in the 
severity of SCD in people with high HbF are not clear. Therefore, studying the associations of HbF 
and clinical phenotypes of SCD may provide insights into the underlying mechanisms. 
Peripheral hemoglobin oxygen saturation (SpO2), measured non-invasively by pulse oximetry, is 
related to several disease complications. Lower SpO2 has been associated with anemia (Quinn and 
Ahmad, 2005), increase in reticulocytes (Quinn and Ahmad, 2005), hemolysis (Campbell et al., 2009) 
and increased episodes of acute chest syndrome (Rackoff et al., 1993) and appears to predict central 
nervous system complications (including stroke (Quinn and Sargent, 2008), higher transcranial 
doppler velocity (Quinn et al., 2009), number of days per year admitted for pain (Hargrave et al., 
2003), tricuspid regurgitant jet velocity (TRV) (Minniti et al., 2009) and diastolic dysfunction (Johnson 
et al., 2010) in SCD.  
Studies in fetuses, children with cyanotic heart disease and adults ascending to high altitude suggest 
that HbF synthesis increases in hypoxia (Bard et al., 1994). Furthermore, hemolysis may induce HbF 
synthesis further (DeSimone et al., 1978). There is limited information on the magnitude and 
direction of any association between HbF and SpO2 in patients with SCD not on hydroxyurea, but the 
available data suggest that, as for neonates (Shiao, 2005), SpO2 is higher in SCD patients with higher 
HbF (Homi et al., 1997),(Halphen et al., 2014, Cox et al., 2013). In this report, we describe the 
association between HbF and SpO2 in individuals with SCD enrolled in the Muhimbili National 
Hospital cohort in Tanzania.  
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MATERIALS AND METHODS 
Study area and population 
This was a cross sectional study conducted at Muhimbili National Hospital (MNH) in Dar-es-Salaam, 
Tanzania involving individuals with SCD recruited into the Muhimbili Sickle cohort between March 
2004 and December 2013. Recruitment and enrolment of patients and diagnosis of SCD has been 
previously described (Makani et al., 2011). Informed consent was obtained for each patient upon 
enrolment. Individuals were identified at pediatric SCD or hematology clinics or during 
hospitalization and were screened for SCD. A diagnosis of sickle cell anemia (HbSS/HbSβ0) by alkaline 
hemoglobin electrophoresis (Helena, Sunderland, Tyne & Wear, UK) was confirmed by high 
performance liquid chromatography (HPLC) (Variant I analyzer, Bio-Rad, Hercules, CA, USA). Ethical 
approval was granted by the Muhimbili University Research and Publications Committee 
(MU/RP/AEC/VOLX1/33). 
Individuals were selected into this study if they had HbF values measured at the age of five years or 
above, since this is the age at which HbF synthesis stabilises. Data were excluded if the patient was 
on hydroxyurea therapy.  
Clinical measures 
Daytime SpO2 was determined in clinic when the child was well using a pulse oximeter (Nellcor, 
Pleasanton, CA, USA). Other clinical information that was collected included pulse rate, systolic 
blood pressure (SBP), and diastolic blood pressure (DBP).  
Laboratory measures 
Hemoglobin was measured by an automated blood cell analyser (ABX Pentra 60 Analyser, Horiba, 
Kyoto, Japan) and reticulocytes were counted using the new methylene blue staining method 
followed by microscopy. HbF measurements were done by HPLC (Variant I, Biorad, Hercules, CA, 
USA). Routine biochemical analysis included total bilirubin (Roche Cobas Mira, New York, USA or 
Abbott Architect, New York, USA). 
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Statistical methods 
The SpO2 data were collected as counts, which ranged from 82-100%, and could not be transformed 
into a normal random distribution, and hence a Poisson random distribution was assumed after 
transformation. To convert the distribution of SpO2 (Figure 1A) into a Poisson distribution, 100-SpO2 
transformation was performed, Figure 1B. The distributions of HbF and bilirubin were positively 
skewed and hence normalized by natural log transformation. The association of clinical and 
laboratory variables with SpO2 (as response variable) was assessed by negative binomial model with 
age and sex included as covariates, presenting the results as rate ratio (RR) with 95% confidence 
intervals..  A p-value <0.05 was considered statistically significant. Variables with significant 
associations with SpO2 in the univariate analysis were included in the multivariable regression 
analysis. 
RESULTS 
We investigated 1,175 individuals (52.1% female, median age 11.2 [IQR: 7.9-16.7] years) with both 
HbF and SpO2 measurements. Median HbF was 4.4% [IQR: 2.4-7.2] and median SpO2 was 98% [IQR: 
96-99]. Table 1 shows the results for the univariable and multivariable analyses. The distribution of 
HbF in relation to SpO2 is presented in Figure 2; which shows the increase in oxygen saturation by 
one unit is associated with increase in mean of log(HbF) by 0.031, (95%CI: 0.013 0.049), p=0.020) 
while other variables are held constant (Table 1). In univariable analysis, SpO2 was directly 
associated with pulse rate, systolic blood pressure (SBP), hemoglobin, and log (HbF) and inversely 
with age, reticulocyte count, and log (total bilirubin) (Table 1). In multivariable regression, log (HbF), 
pulse rate, SBP, and hemoglobin were positively and independently associated with SpO2, while 
reticulocyte count was inversely and independently associated with SpO2 (Table 1). 
DISCUSSION 
This study reports the association of HbF with SpO2 in individuals with SCD.. The study involves one of 
the largest single-centre SCD population to date and the first study to be conducted in an African 
population where the environment is different. This population is composed of a Central African 
Republic (CAR) sickle haplotype of predominatly βS/ βS genotype, a genetic background associated 
with a more severe disease. In addition, the population under study is Hydroxyurea naïve and there 
are limited resources for interventions. These factors make it pertinent f or the study to be 
conducted in this population in order to identify disease-modifying factors that may be amenable to 
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treatment. We have confirmed the association between HbF and SpO2 (Homi et al., 1997). Both HbF 
and total hemoglobin (Hb) were associated with SpO2 independently suggesting that there may be 
separate mechanisms by which increasing Hb and HbF improve SpO2. The association between HbF 
and SpO2 should augment efforts to develop and evaluate interventions that increase both HbF and 
SpO2. Although the mechanism of this association is not known, the oxygen dissociation curve 
properties for HbS and HbF are different. Therefore, the decreased oxygen affinity of hemoglobin S 
(Ueda et al., 1979) may partially contribute to the low SpO2 in SCD. On the other hand, higher levels 
of HbF, which has a higher affinity for oxygen, results in a higher SpO2, in neonates (Shiao, 2005). In 
addition, compounds, including an aromatic aldehyde agent, 5-hydoxymethyl-2-furfural (5-HMF, also 
known as Aes-103), has been found to increase oxygen affinity of sickle hemoglobin and as a result 
reducing hypoxia-induced sickling in vitro and protects sickle cell mice from the effects of hypoxia 
(Safo and Kato, 2014). 
Pulse rate, SBP and hemoglobin were also positively associated with SpO2 in multivariable analysis. 
The direct association of hemoglobin with SpO2 has been described previously and hence confirmed 
in the population that we have studied. The direct association of pulse rate and SBP suggests that 
one of the mechanisms for maintaining an adequate SpO2 is cardiovascular compensation. The HbF 
levels for this population are low compared to other populations with different sickle haplotypes ; 
despite this, an association with SpO2 was established and can be further examined when 
interventions to increase HbF are in place. Treatment trials could examine whether improving SpO2, 
with agents that increase HbF or other methods of improving oxygenation, reduce SBP, a risk factor 
for stroke in adults and children with SCA.  
An association between increased hemolysis  and low SpO2 has been reported (Nouraie et al., 2013). 
In this study, we report an inverse association between SpO2 and total bilirubin and reticulocyte 
count, which are markers of hemolysis, on univariate analysis, suggesting higher SpO2 in the 
presence of lower hemolysis or conversely, increased hemolysis if SpO2 is lower. The effect of 
therapies designed to improve SpO2 or reduce hemolysis may determine whether the initiating 
mechanism for the association involves either low SpO2 or hemolysis. However, total bilirubin may 
also reflect liver compromise and reticulocytosis may be related to the response of the bone marrow 
to non-hemolytic anemia. On multivariable analysis, the reticulocyte count was independently 
associated with SpO2, which suggests an effect on erythropoiesis which may or may not involve 
hemolysis. We could not investigate the relative importance of hemolysis further as we only had 
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total bilirubin for one fifth of the patients; future studies should include measurement of indirect 
bilirubin, as a more specific marker of hemolysis, in all patients.  
This study reports the association of HbF with SpO2two variables with strong clinical significance in 
individuals with SCD. The underlying mechanism of this association and the optimal range for HbF, 
measures cardiac function such as blood pressure and pulse,  and SpO2 for good health in SCD need 
to be established. This information will aid in the development and improvement of HbF-augmenting 
agents. The findings from this study may be applied to other SCD populations that may be similar.  
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Table 1: Association between SpO2(%) and clinical and laboratory parameters in Sickle cell disease  
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Parameters   SpO2,(%) Univariable SpO2 (%), multivariable, N= 632 
 N  RR  95%CI  P  RR  95%CI  P  
Age (years)  1175  0.99  0.89, 0.99  0.024  0.99  0.98, 1.01  0.422  
Sex  1175  0.93  0.83, 1.04  0.191  0.91  0.78, 1.07  0.265  
Pulse rate 
(beats/minute)  
1170  1.00  1.00, 1.01  0.020  1.01  1.00, 1.01  0.026  
Systolic Blood 
Pressure 
(mmHg)  
1167  1.01  1.00, 1.01  0.009  1.008  1.00, 1.02  0.014  
Log (HbF [%])  1175  1.19  1.08, 1.31  0.0004  1.191  1.04, 1.37  0.013  
Hemoglobin 
(g/dL)  
1136  1.07  1.07, 1.12  0.001  1.120  1.05, 1.19  <0.001  
Reticulocyte 
count (*109/L)  
661  0.99  0.98, 1.00  0.043  0.985  0.97, 0.99  0.019  
Log(Bilirubin 
total [mg/dl])  
228  0.65  0.54, 0.77  <0.001     
 
 
 
 
 
 
 
Figure Legends 
Figure 1: Distribution of SpO2 before (A) and after (B) transformation. Conversion of the 
distribution of SpO2 (Figure 1A) into a Poisson distribution, 100-SpO2 transformation was performed 
resulting in the distribution shown in Figure 1B.   
Figure 2: Distribution of mean log (HbF) levels by Oxygen saturation. The dotted line show the 
linear fit of the mean levels, which shows positive association with the increase with the oxy sat. The 
increase in oxy sat by one unit is associated with increase in mean of log(HbF) by  0.031, (95%CI: 
0.013 0.049), p=0.020) 
. 
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